Sunday, April 3, 2022

// // Leave a Comment

Milind Desai, MD: Next Steps for Mavacamten for Hypertrophic Cardiomyopathy

In an interview with HCPLive, principal investigator Milind Desai, MD, Cleveland Clinic, discussed what these results meant for patients with HCM and how they might transform the treamtment of the condition going forward. He ...

from Google Alert - health https://ift.tt/f85GKMI
via IFTTT

0 comments:

Post a Comment